Article Details

Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021

Retrieved on: 2021-03-08 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021. View article details on hiswai:

Excerpt

Roche plans to advance prasinezumab into the Phase 2b PADOVA study in patients with early Parkinson's disease in the second quarter 2021. All three ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up